An A.I.-powered avatar platform aims to restore speech, identity and dignity for people living with ALS and paralysis.

More than 250 community members gathered Saturday morning at Miller/Knox Regional Shoreline in Richmond for the 26th Annual ...

In 2025, Hollywood star Eric Dane shared with the world that he had been diagnosed with a serious disorder that has left him ...

The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen’s UPLIZNA ® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...

The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen's UPLIZNA(R) (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...

In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...

Highlights: FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official entry of NUZ-001 as Regimen I in the HEALEY ALS ...

A local man is using what time he has left to to raise awareness about the financial and emotional toll A-L-S, also known as ...

Using adaptive tools and following ALS kitchen safety strategies can make cooking and eating safer when living with ALS.

Tech companies, a charity and academics have collaborated to create AI-powered avatars that are helping people with motor ...

On November 17, 2025, Congressman Jason Crow introduced H.R. 6001, the Veterans with ALS Reporting Act. The purpose of this Act is to prioritize learning why disabled veterans are more likely than ...

A new wave of expressive, humanlike AI is helping people who cannot speak reclaim presence, connection, and dignity in ...